Seeger Weiss Blog
Seeger Weiss Blog: Legal News and Analysis

Archives : 2011 : November

USA Today: “Acetaminophen can cause liver damage”

November 28th, 2011

A study published in the British Journal of Pharmacology last week confirmed that acetaminophen, the active ingredient in Tylenol, can cause potentially fatal side effects. As USA Today reports, “Taking slightly too much of the pain reliever acetaminophen…over time can lead to an overdose that can cause liver failure and death…”

The experienced drug injury practice of Seeger Weiss LLP investigates claims of liver damage caused by acetaminophen. If you or someone you know has taken a drug containing acetaminophen and suffered liver damage or failure, contact us today. An experienced drug injury attorney with Seeger Weiss LLP will assist you in evaluating your claim. Attorney consultations incur no obligation on your part and all initial consultations are free of charge. Seeger Weiss LLP has office locations in New York, New Jersey, Philadelphia and California.

Fosamax Lawsuits On the Rise, Drug Injury Experts Warn of Fractures

November 8th, 2011

As lawsuits against Fosamax manufacturer, Merck & Co. emerge around the country, drug injury experts are warning patients and doctors about the drug’s harmful side effects. Most notably, the medication, which is indicated to strengthen the bones of those at risk for osteoporosis, has actually been said to make bones weaker, causing an array of unusual problems. Because of such claims, the FDA is expected to publish official warnings about Fosamax later this month. Sheryl Vondracek, an associate professor at the University of Colorado’s Department of Clinical Pharmacy cited in this article, notes that “osteoporosis of the jaw…has been reported with longer term use and atypical fractures, which are fractures of the femur, or thigh bone.”

The experienced drug injury attorneys of Seeger Weiss are actively investigating the claims of those who have been harmed by Fosamax. Click here to visit our Fosamax page.

Drug Injury Claims Cause Actos Sales to Plunge

November 4th, 2011

Reports surfaced early today that profits for Japan-based Takeda Pharmaceutical Co. have substantially declined. One factor that several news sources, including Bloomberg Businessweek, have attributed to the company’s losses is the controversy surrounding its top-selling drug, Actos. Calls for the FDA to release cautionary warnings for the diabetes medication began to emerge after it was linked to an increased risk of bladder cancer. Takeda projects that its net income will plunge by over 30 percent over the course of the next four months.

Seeger Weiss’ highly experienced drug injury practice is closely monitoring reports of bladder cancer associated with Actos. To learn more, visit our Actos investigation page.